Sunny Levine Comments on New SAMHSA Telehealth Proposal
January 10, 2023
Kaiser Health News
Foley & Lardner LLP Associate Sunny Levine is quoted in the Kaiser Health News article, “Behavioral Telehealth Loses Momentum Without a Regulatory Boost,” discussing the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) recent proposal to codify telehealth regulation on opioid treatment programs.
While this proposal only affects part of the sector and leaves unaddressed the process for individual providers to register to prescribe buprenorphine, Levine said the new rules “get us at least a little bit closer to where we need to go.”
This article also ran in CBS News.
Related News
July 24, 2025
In the News
Foley's Trial Team Featured Following Landmark Victory in Texas Trade Secret Case
Foley & Lardner LLP’s recent landmark appellate victory in a Texas trade secrets case is featured in the Texas Lawyer article, "Ruling Sets Precedent for Employment, Trade Secrets, Fiduciary Duty."
July 24, 2025
In the News
Gregory Husisian and David Simon on Tariff Evasion – 'Huge money at stake'
Foley & Lardner LLP partners Gregory Husisian and David Simon detailed the rise and risks of tariff evasion in the POLITICO article, "As Trump raises tariffs, companies find ways to cheat — and risk getting caught."
July 23, 2025
In the News
Aaron Maguregui on AI Scribes in Health Care – 'Technically, it's a third party listening'
Foley & Lardner LLP partner Aaron Maguregui shared insights on the growing applications for artificial intelligence across health care in the healthleaders article, “Is Your AI Scribe HIPAA-Compliant?“